Telesis Bio TBIO reported its Q3 earnings results on Monday, November 13, 2023 at 04:22 PM.
Here's what investors need to know about the announcement.
Earnings
Telesis Bio missed estimated earnings by 23.33%, reporting an EPS of $-0.37 versus an estimate of $-0.3.
Revenue was down $1.11 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 5.76% drop in the share price the next day.
Here's a look at Telesis Bio's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.32 | -0.37 | -0.41 | -0.48 |
EPS Actual | -0.28 | -0.37 | -0.28 | -0.42 |
Revenue Estimate | 8.60M | 7.40M | 7.20M | 5.30M |
Revenue Actual | 8.65M | 6.32M | 9.47M | 6.67M |
To track all earnings releases for Telesis Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.